Transformation by the Src tyrosine kinase (Src) promotes nonanchored cell growth and migration. However, nontransformed cells can force Src-transformed cells to assume a normal morphology and phenotype by a process called 'contact normalization'. It has become clear that microRNA (miRNA) can affect tumorigenesis by targeting gene products that direct cell growth and migration. However, the roles of miRNA in Src transformation or contact normalization have not yet been reported. We examined the expression of 95 miRNAs and found 9 of them significantly affected by Src. In this study, we report that miR-218 and miR-224 were most significantly induced by Src, but not affected by contact normalization. In contrast, miR-126 was most significantly suppressed by Src and was induced by contact normalization in transformed cells. Mir-126 targets Crk, a component of the focal adhesion network that participates in events required for tumor cell migration. Accordingly, we show that miR-126 expression correlates inversely with Crk levels, motility and the invasive potential of human mammary carcinoma cells. Moreover, we show that miR-224 expression promotes nonanchored growth of nontransformed cells. These data reveal novel insights into how Src regulates miRNA expression to promote hallmarks of tumor cell growth and invasion, and how nontransformed cells can affect miRNA expression in adjacent tumor cells to inhibit this process.
Introduction
The Src tyrosine kinase (Src) promotes cell growth and migration that leads to tumor cell invasion and metastasis (Frame, 2004) . Indeed, Src is a clinically relevant tumor promoter that underlies the progression of many types of human cancer (Irby and Yeatman, 2000; Frame, 2002) . The Src kinase phosphorylates Crkassociated substrate (Cas) to promote nonanchored tumor cell growth and migration (Honda et al., 1998; Goldberg et al., 2003; Shin et al., 2004) . Cas is an important component of the integrin signaling network (Bouton et al., 2001) . After phosphorylation by Src, Cas can bind to a number of proteins, including Crk, phosphatidylinositol 3-kinase and Nck (Sakai et al., 1994; Burnham et al., 1996; Vuori et al., 1996) . Specifically, the Cas/Crk association works as a 'molecular switch' to induce cell migration which leads to tumor cell invasion (Klemke et al., 1998) .
Nontransformed cells can force tumor cells to assume a normal morphology and phenotype by a process called 'contact normalization' (Glick and Yuspa, 2005; Rubin, 2006 Rubin, , 2008a Goldberg, 2008) . Genetically transformed cells can assume a normal morphology and reside in many organs, including the breast (Widschwendter et al., 1997; Holst et al., 2003) , intestine (Roberts et al., 2002) and skin (Dotto et al., 1988; Nelson et al., 1992; Aszterbaum et al., 1999) . Indeed, transformed keratinocytes that comprise up to 4% of the epidermal volume can be controlled in human skin for decades (Jonason et al., 1996) . Cells transformed by a variety of chemicals, viral agents and oncogenes, including Src, can be normalized by contact with nontransformed cells (Stoker et al., 1966; Enomoto and Yamasaki, 1984; Bignami et al., 1988; Martin et al., 1991; Goldberg et al., 1994; Esinduy et al., 1995) . We (Alexander et al., 2004) and others (Mehta et al., 1986; Hennings et al., 1990; Vaccariello et al., 1999) have reported that contact normalization requires direct contact between Src-transformed cells and nontransformed cells. Communication by diffusible factors is not sufficient (Alexander et al., 2004) . Tumor cells need to escape the control exerted on them by surrounding nontransformed cells to become malignant and metastatic. However, the mechanisms by which Src promotes tumor cell motility and invasion have not been clearly elucidated. We sought to identify the mechanisms that underlie Src transformation and the ability of transformed cells to overcome contact normalization.
MicroRNA (miRNA) is a class of small RNA molecules that can regulate gene expression post-transcriptionally. miRNA genes are transcribed by RNA polymerase II into primary RNA transcripts that are processed into single-stranded miRNA molecules (Jeffrey, 2008) that have important roles in many biological processes, including embryonic development and tumorigenesis (Caldas and Brenton, 2005; Blenkiron and Miska, 2007; Lee and Dutta, 2008; Medina and Slack, 2008) . For example, miRNA transcripts can function as tumor promotors or tumor suppressors by targeting cancer-related genes involved in cell proliferation, apoptosis or migration (Calin and Croce, 2006) .
In this study we examined miRNA transcripts that are affected by Src transformation and contact normalization. We examined the expression of 95 miRNAs and found 9 that were significantly affected by Src kinase activity. We found that miR-126 was most significantly suppressed by Src and induced by contact normalization in transformed cells. Our data also indicate that miR-126 targets Crk production and inhibits the migration of Src-transformed cells. In addition, we show that miR-126 expression correlates inversely with Crk expression and migration of human mammary carcinoma cells. In contrast to miR-126, we found that miR-218 and miR-224 were most significantly induced by Src, but not affected by contact normalization. We also show that Src induces miR-224 expression to promote the nonanchored growth of transformed cells.
Thus, we report the novel finding that the Crk/Cas complex is coordinately regulated by independent mechanisms by a single transforming kinase: Src activates Cas signaling by phosphorylation, and modulates miRNA expression to increase Crk production. In addition, Src regulates specific miRNAs to promote two fundamental hallmarks of tumor cell growth: Src induces miR-224 and suppresses miR-126 to promote nonanchored cell growth and migration, respectively.
Results
Src transformation and contact normalization affect microRNA (miRNA) expression The Src kinase acts as a very potent tumor promoter, leading to neoplastic morphological transformation and unrestrained cell motility. These hallmarks of tumor cell growth can be reversed and controlled by adjacent nontransformed cells. We have developed a layered culture system to study this phenomenon of 'contact normalization'. In this system, transformed cells and nontransformed cells are separated by a porous membrane, but they are able to contact each other through pores in the membrane (Goldberg et al., 2002; Alexander and Goldberg, 2003; Alexander et al., 2004; Shen et al., 2006) . In this study, we have used this system to analyse the effects of Src transformation and contact normalization on miRNA expression.
We used real-time PCR to examine the expression of miRNA in nontransformed and Src-transformed mouse embryonic brain cells. These cells have been very well characterized, and Src transformation drastically increases their ability to grow in suspension, form multilayered foci and migrate (Alexander et al., 2004; Valiunas et al., 2005a; Shen et al., 2006; Li et al., 2008) . We examined the expression of 95 miRNA species that have been reported to have roles in cancer, cell development or apoptosis. As shown in Figure 1a and Supplementary Table 1, the expressions of nine miRNA species were affected by v-Src (Rous Sarcoma Virus tyrosine kinase). The levels of miR-218, miR-224, miR-142-3p, miR-222 and miR-221 were higher in Srctransformed cells than in nontransformed cells, whereas the expressions of miR-126*, miR-296, miR-194 and miR-206 were lower. Although some other miRNA species, such as miR-185, miR-186 and miR-181c, seemed to be affected by v-Src or contact normalization in Figure 1a , the differences between nontransformed and transformed cells were not considered statistically significant (P>0.1 by t-test).
Out of the nine miRNA species affected by v-Src, only miR-126* and miR-194 were conversely affected by contact normalization, with miR-126* being the most significantly affected (Po0.05 by t-test). As indicated in Figure 1b , v-Src decreased the expression of miR-126* to about 30.5% of the levels observed in nontransformed cells. In addition, contact normalization doubled the expression of this miRNA species to about 65.8% of the levels observed in nontransformed cells.
As pre-miR-126 can produce two mature miRNAs (miR-126 and miR-126*), and miR-126 has been previously reported to suppress tumor cell proliferation (Tavazoie et al., 2008) , we also designed primers to evaluate miR-126 expression. As shown in Figure 1b , v-Src decreased miR-126 expression to about 8.8% of the levels found in nontransformed cells. Moreover, contact normalization doubled miR-126 expression in transformed cells to about 19.6% of the levels observed in nontransformed cells.
Although miR-126 was most significantly suppressed by v-Src, miR-218 and miR-224 were most significantly induced by v-Src. As shown in Figure 1b , the expression of miR-218 and miR-224 was dramatically higher in v-Src-transformed cells than in nontransformed cells. In fact, v-Src increased the expression of miR-218 by over 80-fold and miR-224 by over 30-fold. However, in contrast to miR-126, the expression of these miRNA species was not affected by contact normalization. These results indicate that the miRNAs most affected by v-Src were not necessarily also affected by contact normalization.
Src regulates miR-224 and miR-126 expression to promote cell growth and migration, respectively We hypothesized that Src regulates the expression of miR-126, miR-218 or miR-224 to promote the growth and migration of transformed cells. To test this hypothesis, we stably transfected Src-transformed cells with a miR-126 precursor construct, and nontransformed cells with a miR-218 precursor construct or miR-224 precursor construct. As shown in Figure 2a , transfection with miR-126, miR-218 or miR-224 precursor constructs effectively increased their respective mature miRNA expression compared with the empty vector control.
The expression of miR-126 induced contact growth inhibition and decreased the migration of Src-transformed cells. As shown in Figure 2b 
Figure 1
The Src tyrosine kinase and contact normalization regulate microRNA (miRNA) expression. RNA was purified from nontransformed cells, Src-transformed cells and also from Src-transformed cells that were normalized by contact with nontransformed cells in a layered culture system. The expression of each miRNA species was analysed using real-time PCR and normalized to endogenous U6 small nuclear RNA (snRNA Figure 2d and Supplementary Figure 1 , nontransformed cells transfected with miR-224 grew over three times more efficiently in suspension than the control transfectants. This effect was significant (Po0.0001 by t-test). In contrast to miR-224, miR-218 expression did not significantly affect the ability of nontransformed cells to grow in suspension (Figure 2d and Supplementary Figure 1 ). As expected, Src-transformed cells grow much better than nontransformed cells in nonanchored conditions. As shown in Figure 2d , miR-126 expression did not affect the nonanchored growth of these transformed cells. However, as described above, miR-126 expression affected the motility of transformed cells as opposed to their anchorageindependent growth.
Src suppresses miR-126 expression to augment Crk production in order to promote tumor cell migration miR-126 has recently been shown to target the 3 0 untranslated region of Crk and suppress tumor cell proliferation and invasion (Crawford et al., 2008; Tavazoie et al., 2008) . As shown in Figure 3a , miR-126 contains significant complimentarity to the 3 0 untranslated region of the Crk gene. We used reverse transcriptase-PCR (RT-PCR) to find that miR-126 expression was downregulated in Src-transformed cells, whereas the expression of its host gene, epidermal growth factor-like domain 7 (Egfl7), was not affected (see Figure 3b and Discussion). As shown in Figure 3c , miR-126 expression resulted in a clear decrease in Crk expression, although Src kinase activity was not reduced in these transformed cells. These data support the hypothesis that miR-126 can reduce the expression of Crk in Src-transformed cells.
Src inhibited miR-126 expression to argument Crk production in transformed cells, whereas nontransformed cells induced miR-126 expression to suppress Crk production in the adjacent tumor cells. As shown in Figures 3d and e, Src-transformed cells expressed over twice as much Crk as nontransformed cells grown in standard culture dishes (Figure 3d ) or on membranes in the layered culture system (Figure 3e ). In addition, as shown in Figure 3e miR-126 expression decreases Crk production and inhibits the migration of human mammary carcinoma cells Analyses of human mammary carcinoma cells confirmed that miR-126 could target Crk to reduce tumor cell motility. Consistent with previous reports (Srinivasan and Plattner, 2006; Blick et al., 2008) , two highly invasive estrogen-independent cell lines, MDA-MB-231 and BT-549, migrated about 15 times better than estrogen-dependent and less aggressive MCF-7 cells (see Figure 4c and Supplementary Figure 2) . The motility of these tumor cells correlated with their Crk protein expression levels, and was inversely proportional to their miR-126 expression levels. As shown in Figures  4a and b , MDA-MB-231 cells expressed approximately 37% of the levels of miR-126 and six times the levels of Crk found in MCF-7 cells. BT-549 cells expressed even less miR-126 and more Crk, with 13% of the miR-126 and 10 times the Crk levels found in MCF-7 cells. BT-549 cells also showed a relatively higher level of Src activity, which may be related to the molecular signaling involved in these carcinoma cells (Srinivasan and Plattner, 2006; Blick et al., 2008) .
BT-549 cells were transfected with the miR-126 expression construct or the empty parental vector to verify the effects of miR-126 on Crk expression and tumor cell migration. As shown in Figure 4d , miR-126-transfected BT-549 cells expressed significantly more miR-126 than control transfectants. This increased miR-126 expression resulted in a noticeable decrease in Crk Figure 3 Src tyrosine kinase activity suppresses miR-126 expression to increase Crk production in transformed cells, which is decreased by contact normalization. (a) miR-126 is encoded in the seventh intron of the gene encoding epidermal growth factor-like domain 7 (EGFL7) and is predicted to target the 3 0 untranslated region of mRNA encoding Crk in human and mouse by homology as indicated. (b) The expression of miR-126, EGFL7 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was examined using reverse transcriptase-PCR (RT-PCR) and gel electrophoresis of RNA purified from nontransformed and Src-transformed cells. The expression of miR-126 was suppressed in Src-transformed cells, whereas mRNA encoding EGFL7 and GAPDH were not affected. (c) An equal amount of protein (15 mg/lane) from Src-transformed cells transfected with miR-126 precursor construct or empty vector control was analysed using western blotting with antiserum specific for Crk, active Src (p-Src) or b-actin as indicated. Nontransformed and Src-transformed cells were cultured (d) alone in standard tissue culture dishes or (e) alone or cocultured on opposite sides of porous membranes in a layered cultured system. After 24 h, an equal amount of total protein (15 mg/lane) was analysed using western blotting with antiserum specific for Crk, active Src (p-Src) or b-actin as indicated. Crk protein expression was quantitated and shown as the percentage of nontransformed cells (mean þ s.e.m., n ¼ 3). Triple asterisks indicate Po0.001 compared with control transfectants, respectively (by t-test). Figure 4g and Supplementary Figure 2) . Indeed, miR-126 decreased the migration of these cells quite significantly (Po0.001 by t-test). These data indicate that miR-126 can decrease Crk expression and inhibit the migration of highly aggressive mammary carcinoma cells.
expression (see Figures 4e and f) and cell migration (see
BT-549 cells were treated with the PP2 Src kinase inhibitor to verify that Src kinase activity suppressed miR-126 expression to increase Crk expression and cell Src, miRNA, cell growth and migration X Li et al migration. As shown in Figure 4e , PP2 inhibited Src kinase activity, resulting in a significant increase in miR-126 expression (Figure 4g ). As expected, these events led to a significant decrease in Crk expression (Figures 4e  and f) , and decrease in cell migration (Figure 4h ) similar to that observed in miR-126 transfectants (Figures 4e,  f and h ). These data confirm that Src kinase activity is responsible for suppression of miR-126 expression, which results in increased Crk expression and cell migration.
Discussion
The ability of tumor cells to migrate lies at the core of their malignant and metastatic growth potential. The Src kinase phosphorylates Cas, which can then bind to Crk and promote tumor cell migration. In addition, our data reveal the unexpected finding that Src modulates miRNA expression to augment Crk production in transformed cells. These data indicate that Src has developed the pleiotropic ability to activate the focal 
% Controls
Src, miRNA, cell growth and migration X Li et al adhesion complex by promoting Crk expression, while at the same time modifying its aptly named binding partner Cas to promote cell motility. These studies indicate that Src can stimulate Cas and Crk signaling by two independent mechanisms: (1) activation of Cas signaling by phosphorylation and (2) increasing Crk expression by suppressing miR-126 levels. In addition, as shown schematically in Figure 5 , this second event is inhibited in transformed cells undergoing contact normalization by adjacent nontransformed cells. Transformed cells that 'break away' from this form of growth control would be able to migrate and become invasive.
We examined 95 miRNA sequences that have been implicated as tumor promoters or suppressors. Out of these 95 miRNA species, the expression of nine was affected by transforming Src kinase activity by our filtration criteria, and 2 of these were found to be affected by contact normalization. Thus, by extrapolation, only about 1 or 2% of miRNA species involved in cancer may be involved in the process of contact normalization. These miRNA species, including miR-126, are likely to have important roles in cancer, as overcoming contact normalization is a crucial event leading to malignancy and metastasis. Nonetheless, other miRNA species affected by Src transformation, including miR-218 and miR-224, may also have important roles in cancer progression (Murakami et al., 2006; Zanette et al., 2007; Guo et al., 2008; Ladeiro et al., 2008; Li et al., 2008; Nikiforova et al., 2008; Prueitt et al., 2008; Wang et al., 2008b; Schembri et al., 2009; Wang and Lee, 2009) . Indeed, our results show that Src induces miR-224 expression to promote nonanchored growth of transformed cells, providing a possible explanation for the increased expression of miR-224 observed in a variety of tumors (Murakami et al., 2006; Guo et al., 2008; Ladeiro et al., 2008; Li et al., 2008; Nikiforova et al., 2008; Prueitt et al., 2008; Wang et al., 2008b) . Valiunas et al. (2005b) have shown that RNA molecules of the size of miRNA can transfer between cells through gap junction channels, particularly through channels formed by connexin 43. We used gap junction-deficient Cx43Ko cells to prevent the transfer of miRNA between cell layers in the layered culture system. These cells are well suited to study the contact normalization of Src-transformed cells (Alexander et al., 2004; Shen et al., 2006; Li et al., 2008) . In previous studies, we have shown that Src uses Cas to suppress Fhl1 expression to promote nonanchored tumor cell growth and migration (Shen et al., 2006) .
Recent experiments suggest that Src induces methylation of the Fhl1 gene to suppress its expression in transformed cells (Li et al., 2008) . Although these epigenetic events affecting Fhl1 expression could be detected using mRNA expression analysis (Shen et al., 2006; Li et al., 2008) , post-transcriptional regulation of Crk protein expression by miRNA could not be detected. As shown in Supplementary Figure 3 , Crk mRNA levels were not affected by transforming Src kinase activity or contact normalization. Therefore, this report, being the first that we know of to describe a role for miRNA in Src transformation and contact normalization, suggests that miR-126 suppresses the translation of Crk mRNA as opposed to inducing mRNA degradation.
The sequence encoding miR-126 is located in an intron of the Egfl7 gene (see Figure 3a) . As Egfl7 has been reported to inhibit smooth muscle cell migration (Soncin et al., 2003) , we examined whether Egfl7 and miR-126 are coordinately regulated by Src. The reverse transcriptase-PCR data indicate that, although Src decreased miR-126 expression, Egfl7 mRNA expression levels were not affected (see Figure 3b ). These data are Figure 5 The Src tyrosine kinase activates Cas/Crk signaling using direct and indirect mechanisms. Src phosphorylates Cas, which interacts with Crk to promote cell migration. Src also suppresses miR-126 expression, which would otherwise decrease Crk expression and inhibit tumor cell migration. Nontransformed cells can impede this process by inducing miR-126 expression in adjacent transformed cells. Src also induces the expression of miR-224 to promote nonanchored cell growth, which is not apparently affected by contact normalization. consistent with those of Wang et al. (2008a, b) , and support the possibility that miRNA expression may be controlled by independent regulatory sequences.
miRNA can inhibit the production of target genes by binding to the 3 0 untranslated region of target mRNA (Bartel, 2004) . The intersection of results from PicTar and TargetScan was used to predict miRNA targets (Sethupathy et al., 2006) , and helped identify 11 potential targets of miR-126 (see Supplementary Table  2) . Among these predictions, miR-126 has been reported to target mRNA encoding Crk (Crawford et al., 2008) , insulin receptor substrate 1 and Spred1 (Fish et al., 2008; Kuhnert et al., 2008; Wang et al., 2008a) . Although all these three genes may have potential roles in tumor progression, the importance of miR-126 targeting Crk is clear. Crk is a component of the focal adhesion complex that is involved in integrin signaling. Increased Crk expression has been associated with an aggressive phenotype of carcinomas . In addition, v-Crk can induce cellular tyrosine phosphorylation and transformation of chicken embryo fibroblasts (Akagi et al., 2000) . Furthermore, knockdown of Crk expression can significantly decrease the migration of human cancer cell lines (Rodrigues et al., 2005) .
Indeed, the effects of miR-126 expression on Src transformation and contact normalization are likely to be complex. For example, Liu et al. (2009) have recently found that miR-126 can target vascular endothelial growth factor A (Vegfa) to inhibit cell growth. However, although our analysis did not identify vascular endothelial growth factor A as a prime target of miR-126, our data indicate that Src induces the expression of its receptor, Vefgr2 (Olsson et al., 2006) . Moreover, our data shown in Supplementary Figure 4 suggest that vascular endothelial growth factor receptor-2 expression is significantly reduced in transformed cells undergoing contact normalization. Thus, modulation of numerous miR-126 targets is likely to affect key events during cell transformation and contact normalization.
Regardless of other targets, our data clearly indicate that Src suppresses miR-126 expression to augment Crk production in order to promote tumor cell growth and migration. Highly motile Src-transformed mouse embryonic brain cells expressed lower levels of miR-126 and higher levels of Crk than nontransformed control cells. In addition, highly invasive MDA-MB-231 and BT-549 human mammary cells expressed lesser miR-126 and more Crk than noninvasive MCF-7 cells. Moreover, transfection of these cells with miR-126 resulted in a significant decrease in Crk expression and cell migration. Interestingly, BT-549 cells expressed relatively high levels of active Src kinase. However, although MDA-MB-231 cells did not show remarkably high levels of Src activity, these cells seem to have enhanced levels of cMyc oncogene expression (Dubik et al., 1987) . Thus, in addition to Src, other oncogenes, such as c-Myc, may also suppress miR-126 to promote tumorigenesis. An important aspect of our findings is that although miR-126 expression is reduced in these tumor cells, nontransformed cells may increase miR-126 levels to inhibit Crk expression and migration of adjacent transformed cells. In addition, our data reveal that Src induces miR-224 expression to promote the growth of nonanchored cells, and that this effect is, evidently, not affected by contact normalization. Elucidation of these processes should lead to novel strategies that effectively detect and treat invasive cancer cells.
Materials and methods

Cell culture
The nontransformed and v-Src-transformed mouse embryonic Cx43Ko brain cells (Alexander et al., 2004) , human mammary carcinoma MDA-MB-231 cells, BT-549 cells (kindly supplied by Xiaofeng Ye and Reuben Lotan) and MCF-7 cells were maintained in Dulbecco's modified Eagle's medium (HyClone SH30021.01) supplemented with 25 mM HEPES and 10% bovine growth serum (Hyclone SH30541.03; HyClone, Logan, UT, USA) at 37 1C in 5% CO 2 , and 100% humidity. Cells cultured using standard methods or in a layered culture system were used to examine the effects of v-Src transformation and contact normalization on gene expression as described (Alexander et al., 2004; Shen et al., 2006) . In brief, nontransformed cells (600 000) were plated onto inverted Transwell inserts (Costar 3452; Corning, Corning, NY, USA) that were flipped into six-well plates before Srctransformed cells (300 000) were added to each insert over nontransformed cells. The nontransformed and Src-transformed cells were also plated alone as controls.
MicroRNA (miRNA) transfection miR-126, miR-218 or miR-224 precursor sequences were released from full-length constructs (System Biosciences nos. PMIRH126PA-1, PMIRH218-1PA-1 or PMIRH224PA-1; System Biosciences, Mountain View, CA, USA) with NheI and NotI and subcloned into the complementary sites of pcDNA3.1/Hygro( þ ) (Invitrogen, Carlsbad, CA, USA). These constructs (or the empty parental vector as a control) were then stably transfected into v-Src-transformed or nontransformed mouse embryonic brain cells using Lipofectamine 2000 reagent (Invitrogen) and stable transfectants were selected by growth in hygromycin as described Shen et al., 2006; Li et al., 2008) .
MicroRNA (miRNA) expression analysis RNA was extracted from cells with TRI reagent (Sigma T9424; Sigma, St Louis, MO, USA) and used to synthesize complementary DNA with the QuantiMir kit (System Biosciences no. RA420A-1). Real-time PCR was performed with an Applied Biosystems 7500 real-time PCR system with miRNA-specific primers (System Biosciences no. CSRA640A-1) and power SYBR master mix (Applied Biosystems no. 4368706; Applied Biosystems, Foster City, CA, USA). Reactions were incubated in 96-well plates at 50 1C for 2 min and at 95 1C for 10min followed by 40 cycles of 15 s at 95 1C and 1 min at 60 1C. The relative expression of each miRNA species was calculated and normalized to endogenous U6 small nuclear RNA using the comparative C T method (Livak and Schmittgen, 2001 Li et al., 2008) . Rabbit antiserum was used to detect active Src Kinase (phosphorylated at Y416, Cell Signaling Technology, Danvers, MA, USA, 2101). Mouse monoclonal antiserum was used to detect Crk (BD Transduction Laboratories, 610035) or actin (Sigma, A1978). Primary antiserum was recognized by the appropriate secondary antiserum conjugated to horseradish peroxidase and detected using ECL reagents (Millipore). Signal was quantitated using ImageJ software (National Institutes of Health, version 1.38 Â ).
Reverse transcriptase-PCR RNA was purified from cells using TRI RNA Isolation Reagent (T9424, Sigma). First-strand complementary DNA was synthesized with 1 mg of RNA with the protoscript firststrand complementary DNA synthesis kit (E6500S, New England Biolabs, Ipswich, MA, USA). PCR was performed with primers specific for glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 5 0 -TGCATCCTGCACCACCAACT-3 0 and 5 0 -GCCTGCTTCACCACCTTC-3 0 ), Egfl7 (5 0 -ATATGC CAGCCTCCATGTGGGAAT-3 0 and 5 0 -TCTGCAGATGGG CTTTGTCCCT-3 0 ) and miR-126 (5 0 -CATTATTACTTTTGG TACGCG-3 0 and 5 0 -CGCATTATTACTCACGGTACGA-3 0 ) with GoTag Green Master Mix (M7122, Promega, Madison, WI, USA). Products were resolved in 5% polyacrylamide gels and visualized using ethidium bromide staining.
Statistical analysis
Data were analysed using Vector Xpression 4.1 (Invitrogen) and Prism (Graphpad, La Jolla, CA, USA) software.
Cell growth and migration assays Cells (20 000 cells per well) were seeded in tissue culture-treated 12-well cluster plates (Falcon, BD Biosciences, San Jose, CA, USA, 3043) to determine anchored growth, or in ultra-lowattachment 24-well cluster plates (Corning, 3473) to determine nonanchored growth as previously described (Shen et al., 2006) . Cell numbers were counted using Coulter counter at the indicated time points. To measure cell migration, 200 000 cells were plated on Transwell inserts (Costar no. 3428) with an 8-mm pore size in six-well cluster plates and cultured for 24 h. Cells were then separately digested from each side of the membrane and counted as described (Shen et al., 2006) . Cell migration was also analysed by an in vitro wound-healing assay, in which confluent layers of cells were scratched with a plastic pipette tip, washed with fresh medium and cultured for 24 h. The number of cells entering the wound was counted from phase-contrast images obtained with a digital camera (AxioCam MRm) attached to a Zeiss microscope (Axiovert 40 CFL) equipped with Axiovision 4.5 software. Comparative experiments were performed in parallel to minimize the potential effects of variations in culture conditions.
PP2 treatment
Cells were treated with 10 mM PP2 (AG1879, Calbiochem, Madison, WI, USA) in dimethylsulphoxide (D2650, Sigma), or solvent alone as a control (1% final concentration) after scraping monolayers with a pipette tip for wound-healing assays. Cells were then analysed using wound-healing assays or western blotting as described above.
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